First Tracks Biotherapeutics
Filed with the SEC on · accession 9999999995-26-003380
TRAX filed a EFFECT (effect) with the SEC on Oct 29, 2026. First Tracks Biotherapeutics filed an EFFECT notice indicating the SEC declared a registration statement effective. The stock moved -1.1% by the first close after the filing.
First Tracks Biotherapeutics filed an EFFECT notice indicating the SEC declared a registration statement effective. The filing is a routine effectiveness notice with no substantive details disclosed in the available text.
Close before
$45.72
Oct 28, 2026
First close after
-1.08%
$45.23
5 trading days
+7.26%
$49.04
Since filing
+4.77%
$47.90
✦ Ask GOAX AI about this filing — what it means for TRAX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TRAX?
Click hereTRAX filed a EFFECT (Shelf registration). First Tracks Biotherapeutics filed an EFFECT notice indicating the SEC declared a registration statement effective. The filing is a routine effectiveness notice with no substantive details disclosed in the available text.
New shares dilute existing holders and are often sold at a discount to the market price.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
TRAX closed at $45.72 before the filing and $45.23 on Oct 29, 2026 (-1.08%). Five trading days later: $49.04 (+7.26%).
Get alerts when TRAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days